Vasculogenic mimicry in testicular germ cell malignant tumor and its significance for prognosis

Chinese Journal of Clinical Oncology

Volumn 36, Issue 2, 2009, Pages 78-82

  Wang, Xiaoyu ^a   Wang, Lin ^a   Gu, Yanjun ^a   Zhang, Shiwu ^a   Zhao, Xiulan ^a   Sun, Baocun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Prognosis; Testicular germ cell malignant tumors; Vasculogenic mimicry

Indexed keywords

CD34 ANTIGEN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; GERM CELL TUMOR; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STAINING;

EID: 77951551890     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2009.02.006     Document Type: Article

References (13)

1. Denk AE, Bettstetter M, Wild PJ, et al. Loss of maspin expression contributes to a more invasive potential in malignant melanoma [J]. Pigment Cell Res, 2007, 20(2): 112-119. (Pubitemid 46439520)
2. Döme B, Hendrix MJ, Paku S, et al. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications[J]. Am J Pathol, 2007, 170(1): 1-15. (Pubitemid 47339184)
3. Hendrix MJ, Seftor EA, Hess AR, et al. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma[J]. Nat Rev Cancer, 2003, 3(6): 411-421.
4. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma[J]? J Histochem Cytochem, 2005, 53(8): 997-1002.
5. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis[J]. Am J Pathol, 2000, 156(2): 361-381.
6. Sun B, Qie S, et al. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors[J]. Human Pathol, 2008, 39(3): 441-451. (Pubitemid 351186697)
7. Li HW, Leung SW, Chan CS, et al. Expression of maspin in endometrioid adenocarcinoma of endometrium[J]. Oncol Rep, 2007, 17(2): 393-398.
8. Mhawech-Fauceglia P, Dulguerov P, Beck A, et al. Value of ezrin,maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy[J]. J Clin Pathol, 2007, 60(2): 185-189. (Pubitemid 46245783)
9. Maniotis AJ, Folberg R, Hess A, et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J]. Am J Pathol, 1999, 155(3): 739-752. (Pubitemid 29426820)
10. Zhang S, Zhang D, Sun B. Vasculogenic mimicry: current status and future prospects[J]. Cancer Lett, 2007, 254(2): 157-164. (Pubitemid 47126687)
11. Lutgendorf SK, Johnsen EL, Cooper B, et al. Vascular endothelial growth factor and social support in patients with ovarian carcinoma[J]. Cancer, 2002, 95(4): 808-815. (Pubitemid 34839673)
12. Wang JY, Sun T, Zhao XL, et al. Functional significance of VEGF-a in human ovarian carcinoma:role in vasculogenic mimicry[J]. Cancer Biol Ther, 2008, 7(5): 758-766. (Pubitemid 351847015)